✦ LIBER ✦

Tesaglitazar, a novel dual peroxisome proliferator-activated receptor α/γ agonist, dose-dependently improves the metabolic abnormalities associated with insulin resistance in a non-diabetic population

✍ Scribed by B. Fagerberg; S. Edwards; T. Halmos; J. Lopatynski; H. Schuster; S. Stender; G. Stoa-Birketvedt; S. Tonstad; S Halldórsdóttir; I. Gause-Nilsson

Publisher: Springer
Year: 2005
Tongue: English
Weight: 241 KB
Volume: 48
Category: Article
ISSN: 0012-186X
DOI: 10.1007/s00125-005-1846-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A novel dual peroxisome proliferator-act

A novel dual peroxisome proliferator-activated receptors α and γ agonist with beneficial effects on insulin resistance and lipid metabolism

✍ Cheng Xu; Li-Li Wang; Hong-Ying Liu; Cheng-Mai Ruan; Xing-Bo Zhou; Ying-Lin Cao; 📂 Article 📅 2006 🏛 Springer Netherlands 🌐 English ⚖ 222 KB

A polymorphism, L162V, in the peroxisome

A polymorphism, L162V, in the peroxisome proliferator-activated receptor α (PPARα) gene is associated with lower body mass index in patients with non-insulin-dependent diabetes mellitus

✍ D. Evans; J. Aberle; D. Wendt; A. Wolf; U. Beisiegel; W.A. Mann 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 71 KB